Pharmacological inhibition of key metabolic pathways attenuates Leishmania spp infection in macrophages
Authors:
Open Access
- 7 January 2025
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 19 (1) , e0012763
Abstract
Macrophages represent a fundamental component of the innate immune system that play a critical role in detecting and responding to pathogens as well as danger signals. Leishmania spp. infections lead to a notable alteration in macrophage metabolism, whereby infected cells display heightened energy metabolism that is linked to the integrity of host mitochondria. However, little is known about how different species of Leishmania manipulate host metabolism. Here, we demonstrate that despite differences in their mechanisms for evading host immune responses, L. amazonensis and L. braziliensis induce comparable disruptions in key metabolic pathways. We found that infected macrophages exhibited an overall elevation in energy metabolism regardless of the parasite strain, evidenced by the elevation in glycolysis and oxygen consumption rates, along with increased proton leak and decreased ATP production. We also analyzed the effects of both Leishmania spp. strain infection on mitochondria function, further revealing that infected cells display heightened mitochondrial mass and membrane potential. To investigate the metabolic pathways required for Leishmania amastigotes to persist in BMDMs, we pre-treated cells with small molecule drugs that target major metabolic pathways, revealing that perturbations in several metabolic processes affected parasite survival in a strain-independent manner. Treatments with inhibitors of the oxidative phosphorylation and glycolysis substantially reduced parasite loads. Collectively, our findings suggest that L.amazonensis and L.braziliensis exploit host cell metabolic pathways similarly to survive in macrophages.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (21/01147-1)
- Fundação de Amparo à Pesquisa do Estado da Bahia (APP0108/2016)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/16030-0)
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2022/04576-3)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (476926/2011-4)
- Fundação Oswaldo Cruz (920285408)
- National Council for Scientific and Technological Development (309283/2022-1)
- National Council for Scientific and Technological Development (309901/2023-5)
- National Council for Scientific and Technological Development (17021/2021-4)
- National Council for Scientific and Technological Development (304280/2020-8)
- National Council for Scientific and Technological Development (304876/2019-4)
This publication has 29 references indexed in Scilit:
- Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent AxisCell Metabolism, 2020
- Macrophages and lipid metabolismCellular Immunology, 2018
- Extracellular ATP signaling and clinical relevanceClinical Immunology, 2018
- Macrophage Immunometabolism: Where Are We (Going)?Trends in Immunology, 2017
- Host Metabolism Regulates Intracellular Growth of Trypanosoma cruziCell Host & Microbe, 2013
- Mitochondrial complex III: An essential component of universal oxygen sensing machinery?Respiratory Physiology & Neurobiology, 2010
- A drug-selected Plasmodium falciparum lacking the need for conventional electron transportMolecular and Biochemical Parasitology, 2008
- Living in a phagolysosome; metabolism of Leishmania amastigotesTrends in Parasitology, 2007
- Metabolism of Leishmania: proven and predictedTrends in Parasitology, 2007
- Leishmaniasis: current situation and new perspectivesComparative Immunology, Microbiology and Infectious Diseases, 2004